Article
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort…
Drug Design, Development and Therapy · 2022 · Spagnuolo V, Voarino M, Tonelli M, Galli L, Poli A, Bruzzesi E, Racca S, Clementi N, Oltolini C, Tresoldi M, Rovere Querini P, Dagna L, Zangrillo A, Ciceri F, Clementi M, Castagna A
Key facts
| Title | Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study |
|---|---|
| First author | Spagnuolo V, Voarino M, Tonelli M, Galli L, Poli A, Bruzzesi E, Racca S, Clementi N, Oltolini C, Tresoldi M, Rovere Querini P, Dagna L, Zangrillo A, Ciceri F, Clementi M, Castagna A |
| Journal | Drug Design, Development and Therapy |
| Published | Oct 19, 2022 |
| DOI | 10.2147/DDDT.S369473 |
| Devices mentioned | 214787, K000534, K003865, K021512, K023296, K024098, K031824, K031879, K033009, K033185, K051890, K052982 and 31 more |
| Product codes mentioned | CDS, CEM, CGA, CGZ, CHL, DLJ, GKR, JIL, JIT, JIX, JJE, JJF and 34 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1